Results 111 to 120 of about 38,752 (185)

Unlocking binding properties of single-domain antibodies targeting the polymeric immunoglobulin receptor to enhance mucosal enrichment of IgG against respiratory syncytial virus. [PDF]

open access: yesFront Immunol
Liu J   +18 more
europepmc   +1 more source

Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential. [PDF]

open access: yesJ Biol Chem
Golonka RM   +10 more
europepmc   +1 more source

Affinity- and Format-Dependent Pharmacokinetics of 89Zr-Labeled Albumin-Binding VHH Constructs. [PDF]

open access: yesPharmaceuticals (Basel)
Leekens S   +7 more
europepmc   +1 more source

Entire VHH-MMSI completed

open access: yes
Integration of media analytics components with the VHH Media Management and Search Infrastructure is completed and the entire VHH-MMSI is finalised.
openaire   +1 more source

CD4 T-cell platform for delivering interferons as an antiviral countermeasure with a focus on SARS-CoV-2. [PDF]

open access: yesMol Med
Liu X   +6 more
europepmc   +1 more source

Systematic perturbation of cultures of K. phaffii by carbon co-feeding show gene signatures associated with production of recombinant proteins. [PDF]

open access: yesMicrob Cell Fact
Acharya R   +8 more
europepmc   +1 more source

Structural Basis of MERS-CoV Receptor Interactions and Antibody Neutralisations. [PDF]

open access: yesRev Med Virol
Gavor E   +5 more
europepmc   +1 more source

A High-Affinity Nanobody Selectively Recognizing KPC-2/KPC-3: Biochemical and Structural Insights. [PDF]

open access: yesBiomolecules
Hamdi E   +10 more
europepmc   +1 more source

Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers. [PDF]

open access: yesRes Pract Thromb Haemost
Alessi MC   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy